DOCUMENT

18 Headlines UK A new tool designed by researchers from the University of Exeter and the University of East Anglia can calculate which medicines are more likely to have adverse side-effects on the body and brain. Many prescription and over-the-counter drugs can cause cognitive side-effects by blocking a key neurotransmitter called acetylcholine. Dr Saber Sami, study co-author, says "Our tool is the first to use innovative artificial intelligence technology. Once further research has been conducted the tool should support pharmacists and prescribing health professionals in finding the best treatment for patients." USA Researchers from the Icahn School of Medicine at Mount Sinai have been using novel artificial intelligence (AI) methods to help determine causes of Alzheimer’s disease and other related conditions. Using deep learning techniques, a branch of AI, the team examined the structural and cellular features of human brain tissues. This unbiased AI-method revealed unexpected microscopic abnormalities that can predict the presence of cognitive impairment. Parkinson's disease is notoriously difficult to diagnose as it relies primarily on the appearance of motor symptoms such as tremors, stiffness, and slowness, but these symptoms often appear several years after the disease onset. Researchers fromtheMassachusetts Institute of Technology have developed an artificial intelligencemodel that can detect Parkinson’s just from reading a person’s breathing patterns while they sleep. Neurological research from around the globe  Canada Researchers from the University of Montreal and Institut Pasteur in France have developed a new neurocomputational model of the human brain which could shed light on how we develop complex cognitive abilities. “Our model demonstrates how the neuro-AI convergence highlights biological mechanisms and cognitive architectures that can fuel the development of the next generation of artificial intelligence," said Guillaume Dumas, study co-author.